Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent, as the drugmakers follow a similar move by rival Amgen Inc in hopes of increasing use of the drug.

BING NEWS:
  • Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
    NEW YORK (Reuters) - Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent, as ...
    02/10/2019 - 11:23 pm | View Link
  • Sanofi and Regeneron cut list price of cholesterol drug by 60%
    Sanofi and Regeneron Pharmaceuticals said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent. Drugmakers are following a ...
    02/10/2019 - 11:18 pm | View Link
  • Sanofi and Regeneron cut list price of cholesterol drug by 60 pct
    NEW YORK, Feb 11 (Reuters) - Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 ...
    02/10/2019 - 11:03 pm | View Link
  • More
BING SEARCH:
  • Sanofi, Regeneron cut list price of cholesterol drug by 60 ...
    Sanofi and Regeneron said they expect the lower-priced Praluent to be available for pharmacies to order in early March. Sanofi, Regeneron cut list price of cholesterol drug by 60% | Fox Business News
    04/20/2019 - 12:20 pm | View Website
  • Regeneron, Sanofi, Cut Cholesterol Drug List Price by 60 ...
    Regeneron and Sanofi are slashing the list price of their blockbuster cholesterol drug, Praluent (alirocumab), by up to 60 percent, the companies announced. Regeneron and Sanofi offered to cut Praluent’s list price last year in exchange for health plans dropping “burdensome access barriers” to the elder patients targeted for care.
    02/16/2019 - 2:12 am | View Website
  • Regeneron, Sanofi cut PCSK9 list price, matching earlier ...
    Regeneron and Sanofi will sharply cut the list price of their cholesterol medicine Praluent in a rare move designed to reduce patient out-of-pocket costs and spur uptake of the biologic drug, the companies announced Monday. Starting in early March, the PCSK9 inhibitor will be available in the U.S ...
    02/11/2019 - 12:05 pm | View Website
  • Sanofi and Regeneron cut list price of cholesterol drug by ...
    Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent, as the drugmakers ...
    02/11/2019 - 7:40 am | View Website
  • Sanofi and Regeneron cut list price of cholesterol drug by 60%
    Sanofi and Regeneron cut list price of cholesterol drug by 60% Sanofi and Regeneron Pharmaceuticals said on Monday that they will slash the U.S. Drugmakers are following a similar move by rival Amgen in hopes of increasing use of the drug. The new list price for Praluent will be $5,850 a year, ...
    02/11/2019 - 7:12 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News